Sonnet Biotherapeutics Holdings Inc
SONN2.746USD
-0.064-2.29%
交易中 （美东）报价延迟15分钟
8.58M总市值
亏损市盈率 TTM
关于 Sonnet Biotherapeutics Holdings Inc 公司
Sonnet BioTherapeutics Holdings, Inc. 是一家临床阶段、专注于肿瘤学的生物技术公司，拥有专有的单功能或双功能生物药物平台。全人白蛋白结合 (FHAB) 是一种利用全人单链抗体片段与人血清白蛋白结合并搭便车运输到目标组织的技术。其 FHAB 旨在专门针对肿瘤和淋巴组织。该公司的领先项目 SON-1010 或 IL-12-FHAB 正在开发中，用于治疗实体瘤和卵巢癌。SON-1010 正在进行 1/2a 期研究，与阿替利珠单抗 (Tecentriq) 联合用于治疗铂耐药性卵巢癌 (PROC)。该公司还在评估其第二个项目 SON-1210，这是一种用于实体瘤的 IL12-FHAB-IL15。其 SON-080 项目是一种低剂量 rhIL-6，用于治疗化疗引起的周围神经病变 (CIPN) 和糖尿病周围神经病变 (DPN)。
公司简介
公司代码SONN
公司名称Sonnet Biotherapeutics Holdings Inc
上市日期Jul 27, 2005
CEOMr. Raghu Rao
员工数量13
证券类型Ordinary Share
年结日Jul 27
公司地址100 Overlook Center
城市PRINCETON
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编08540
电话16093752227
网址https://www.sonnetbio.com/
公司代码SONN
上市日期Jul 27, 2005
CEOMr. Raghu Rao
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Raghu Rao
Mr. Raghu Rao
Interim Chief Executive Officer, Director
Interim Chief Executive Officer, Director
22.36K
+848.90%
Dr. John K. Cini, Ph.D.
Dr. John K. Cini, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
14.12K
+567.11%
Mr. Nailesh Bhatt
Mr. Nailesh Bhatt
Independent Director
Independent Director
10.55K
+1828.15%
Ms. Susan Dexter
Ms. Susan Dexter
Chief Technical Officer
Chief Technical Officer
8.37K
+2139.04%
Dr. Richard T. Kenney, M.D.
Dr. Richard T. Kenney, M.D.
Chief Medical Officer
Chief Medical Officer
8.26K
+3053.44%
Ms. Lori Mcneill
Ms. Lori Mcneill
Independent Director
Independent Director
4.39K
+1015.23%
Mr. Albert D. Dyrness
Mr. Albert D. Dyrness
Independent Director
Independent Director
537.00
+227.44%
Mr. Donald J. Griffith, CPA
Mr. Donald J. Griffith, CPA
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Stephen Mcandrew, Ph.D.
Dr. Stephen Mcandrew, Ph.D.
President and Chief Business Officer
President and Chief Business Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Raghu Rao
Mr. Raghu Rao
Interim Chief Executive Officer, Director
Interim Chief Executive Officer, Director
22.36K
+848.90%
Dr. John K. Cini, Ph.D.
Dr. John K. Cini, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
14.12K
+567.11%
Mr. Nailesh Bhatt
Mr. Nailesh Bhatt
Independent Director
Independent Director
10.55K
+1828.15%
Ms. Susan Dexter
Ms. Susan Dexter
Chief Technical Officer
Chief Technical Officer
8.37K
+2139.04%
Dr. Richard T. Kenney, M.D.
Dr. Richard T. Kenney, M.D.
Chief Medical Officer
Chief Medical Officer
8.26K
+3053.44%
Ms. Lori Mcneill
Ms. Lori Mcneill
Independent Director
Independent Director
4.39K
+1015.23%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月16日 周五
更新时间: 5月16日 周五
持股股东
股东类型
持股股东
持股股东
占比
MMCAP Asset Management
2.13%
Geode Capital Management, L.L.C.
0.40%
Markey (John)
0.40%
Rao (Raghu)
0.36%
Mohan (Pankaj)
0.25%
Other
96.47%
持股股东
持股股东
占比
MMCAP Asset Management
2.13%
Geode Capital Management, L.L.C.
0.40%
Markey (John)
0.40%
Rao (Raghu)
0.36%
Mohan (Pankaj)
0.25%
Other
96.47%
股东类型
持股股东
占比
Hedge Fund
2.17%
Individual Investor
2.03%
Investment Advisor/Hedge Fund
0.40%
Investment Advisor
0.11%
Other
95.29%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
42
216.94K
3.73%
-6.57K
2025Q1
49
216.94K
6.86%
-38.71K
2024Q4
47
142.46K
4.65%
-26.07K
2024Q3
47
41.15K
2.68%
-136.57K
2024Q2
52
111.48K
15.39%
+15.28K
2024Q1
53
47.27K
6.49%
-61.26K
2023Q4
55
63.31K
18.25%
-49.43K
2023Q3
54
43.80K
20.23%
-50.04K
2023Q2
52
54.80K
26.54%
-1.94K
2023Q1
46
43.66K
38.19%
+40.95K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
MMCAP Asset Management
133.59K
4.22%
+133.59K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
24.80K
0.78%
+24.80K
--
Mar 31, 2025
Markey (John)
24.79K
0.78%
-4.10K
-14.20%
Jan 02, 2024
Rao (Raghu)
2.36K
0.07%
+373.00
+18.81%
Dec 16, 2024
Mohan (Pankaj)
15.37K
0.49%
+7.55K
+96.61%
Dec 16, 2024
Cini (John K)
2.12K
0.07%
+1.89K
+828.07%
Dec 16, 2024
Bhatt (Nailesh)
547.00
0.02%
+373.00
+214.37%
Dec 16, 2024
Griffith (Donald J. CPA)
375.00
0.01%
+317.00
+546.55%
Dec 16, 2024
Dexter (Susan)
374.00
0.01%
+182.00
+94.79%
Dec 11, 2023
Kenney (Richard T)
262.00
0.01%
+159.00
+154.37%
Dec 11, 2023
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Aug 31, 2023
Merger
22<1
Aug 31, 2023
Merger
22<1
公告日期
类型
比率
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Aug 31, 2023
Merger
22<1
Aug 31, 2023
Merger
22<1
Aug 31, 2023
Merger
22<1
Aug 31, 2023
Merger
22<1
Sep 16, 2022
Merger
14<1
Sep 16, 2022
Merger
14<1
查看更多
